GeoVax Labs (GOVX) consistently increased its Research and Development (R&D) expenses over the course of 2023 and 2024, with a cumulative expenditure of $20.72 million by the end of 20241. This indicates a strong commitment to innovation and product development during this period.
GOVX R&D Expenses, R&D Expenses YoY
Source:
1.
GOVX R&D Expenses in 2023-2024
more
less
Explore
Screener
Best looking stocks that are MACD Golden Cross
Analysis
What is the trend of APOG's stock price?
Learn
Step 2: Macro context and catalyst, please provide the best sources, websites, and why, in French.
Wiki
For diabetes, what foods or drink are good to consume?